BFC Planning’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
BFC Planning's BIO Position: Q3 2026 in Review
BFC Planning increased its Bio-Rad Laboratories Class A (BIO) stake by 149% in Q3 2026, buying an estimated $18.2K and bringing the position to 87 shares worth $32.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1769.
BFC Planning first reported a position in BIO in Q3 2024 and has held it in 9 quarters since. 339 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- BFC Planning held 87 shares of Bio-Rad Laboratories Class A worth $32.9K as of Q3 2026.
- BFC Planning bought 52 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $18.2K.
- Bio-Rad Laboratories Class A made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1769 holding.
- BFC Planning first reported a position in Bio-Rad Laboratories Class A in Q3 2024 and has held it in 9 quarters since.
- 339 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.